After reaching $1 billion in annualized revenue, Anysphere CEO Michael Truell explained the features his company is focused ...
This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback